VERACYTE, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- VERACYTE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2016-12-31 was 98.82K shares, a 249.66% increase year-over-year.
- VERACYTE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2016-09-30 was 657.00 shares, a 98.92% decline year-over-year.
- VERACYTE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2016-06-30 was 5.97K shares, a 95.62% decline year-over-year.
- VERACYTE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2016-03-31 was 107.30K shares, a 280.27% increase year-over-year.
- VERACYTE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 591.01K shares, a 43.90% decline from fiscal 2024.
- VERACYTE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 1.05M shares, a 71.60% increase from fiscal 2023.
- VERACYTE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 613.89K shares, a 53.08% increase from fiscal 2022.
- VERACYTE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 401.01K shares, a 43.72% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2025-12-31 | 591.01K shares 10-K · filed 2026-02-26 | |
| 2024-12-31 | 1.05M shares 10-K · filed 2025-02-28 | |
| 2023-12-31 | 613.89K shares 10-K · filed 2024-02-29 | |
| 2022-12-31 | 401.01K shares 10-K · filed 2023-03-01 | |
| 2021-12-31 | 712.59K shares 10-K · filed 2022-02-28 | |
| 2020-12-31 | 1.35M shares 10-K · filed 2021-02-22 | |
| 2019-12-31 | 1.85M shares 10-K · filed 2020-02-25 | |
| 2018-12-31 | 740.01K shares 10-K · filed 2019-02-25 | |
| 2017-12-31 | 279.45K shares 10-K · filed 2018-02-27 | |
| 2016-12-31 | 98.82K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | 212.74K shares 10-K · filed 2017-03-01 |
| 2016-09-30 | 657.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | 142.18K shares derived: sum of 4 quarters · filed 2016-11-03 |
| 2016-06-30 | 5.97K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | 202.59K shares derived: sum of 4 quarters · filed 2016-08-03 |
| 2016-03-31 | 107.30K shares 10-Q · filed 2016-05-05 | 332.87K shares derived: sum of 4 quarters · filed 2016-05-05 |
| 2015-12-31 | 28.26K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | 253.79K shares 10-K · filed 2016-03-14 |
| 2015-09-30 | 61.06K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | 258.57K shares derived: sum of 4 quarters · filed 2015-11-05 |
| 2015-06-30 | 136.25K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | 276.77K shares derived: sum of 4 quarters · filed 2015-08-13 |
| 2015-03-31 | 28.22K shares 10-Q · filed 2015-05-15 | 422.96K shares derived: sum of 4 quarters · filed 2015-05-15 |
| 2014-12-31 | 33.05K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-25 | 402.10K shares 10-K · filed 2015-03-25 |
| 2014-09-30 | 79.26K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | -324.14M shares derived: sum of 4 quarters · filed 2015-03-25 |
| 2014-06-30 | 282.44K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | |
| 2014-03-31 | 7.36K shares 10-Q · filed 2014-05-09 | |
| 2013-12-31 | -324.51M shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-25 | 377.97K shares 10-K · filed 2015-03-25 |
| 2012-12-31 | 72.74K shares 10-K · filed 2015-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |